Since the Federal Circuit’s October 5, 2017 decision in Amgen Inc. v. Sanofi overruling the so-called “newly characterized antigen”...
Patent
-
-
Making up only around 7% of post-grant trials at the PTAB (according to statistics released by the USPTO from February 2018), the number of...
-
On Thursday, March 15, 2018, Commissioner for Patents, Andrew Hirshfeld, announced that the USPTO is making progress on its “Access to...
-
In Titanium Metals Corp. v. Banner, the Federal Circuit notably held that it is “an elementary principle of patent law” that when a...
-
The Patent Trial and Appeal Board (“the PTAB”) ruled last Friday, February 23, 2018, that tribal sovereign immunity does not apply to...
-
On Monday, February 12, 2018, the Federal Circuit reversed the Patent Trial and Appeal Board’s (“the Board”) anticipation rejections...
-
On February 9, 2018, in vacating and remanding parts of an obviousness decision, the Federal Circuit found that the Patent Trial and Appeal...
-
The United States Patent and Trademark Office (USPTO) published new and updated guidelines on subject matter eligibility on February 5,...
-
On January 24, 2018, the Federal Circuit affirmed a decision of the Patent Trial and Appeal Board (“PTAB”), finding that 37 C.F.R. §...